Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 16;9(4):186.
doi: 10.3390/antibiotics9040186.

The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria

Affiliations
Review

The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria

Dalal Hammoudi Halat et al. Antibiotics (Basel). .

Abstract

Carbapenemases are β-lactamases belonging to different Ambler classes (A, B, D) and can be encoded by both chromosomal and plasmid-mediated genes. These enzymes represent the most potent β-lactamases, which hydrolyze a broad variety of β-lactams, including carbapenems, cephalosporins, penicillin, and aztreonam. The major issues associated with carbapenemase production are clinical due to compromising the activity of the last resort antibiotics used for treating serious infections, and epidemiological due to their dissemination into various bacteria across almost all geographic regions. Carbapenemase-producing Enterobacteriaceae have received more attention upon their first report in the early 1990s. Currently, there is increased awareness of the impact of nonfermenting bacteria, such as Acinetobacter baumannii and Pseudomonas aeruginosa, as well as other Gram-negative bacteria that are carbapenemase-producers. Outside the scope of clinical importance, carbapenemases are also detected in bacteria from environmental and zoonotic niches, which raises greater concerns over their prevalence, and the need for public health measures to control consequences of their propagation. The aims of the current review are to define and categorize the different families of carbapenemases, and to overview the main lines of their spread across different bacterial groups.

Keywords: Gram-negative bacteria; KPC; carbapenemases; metallo-β-lactamases; oxacillinases; resistance; β-lactamases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Worldwide distribution of KPC, NDM, VIM, IMP, SME, SPM, and OXA-48 carbapenemases with a status of dissemination. E = endemic. S = sporadic. N = newly detected. KPC = Klebsiella pneumoniae carbapenemase. NDM = New Delhi metallo-β-lactamase. VIM = Verona-intergon-encoded metallo-β-lactamase. IMP = imipenemase, SME = Serratia marcescens enzyme, SPM = Sao Paulo metallo-β-lactamase. OXA = oxacillinase.

References

    1. Jean S.-S., Lee W.-S., Lam C., Hsu C.-W., Chen R.-J., Hsueh P.-R. Carbapenemase-producing Gram-negative bacteria: Current epidemics, antimicrobial susceptibility and treatment options. Future Microbiol. 2015;10:407–425. doi: 10.2217/fmb.14.135. - DOI - PubMed
    1. Bonomo R.A., Burd E.M., Conly J., Limbago B.M., Poirel L., Segre J.A., Westblade L.F. Carbapenemase-Producing Organisms: A Global Scourge. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2018;66:1290–1297. doi: 10.1093/cid/cix893. - DOI - PMC - PubMed
    1. Kanj S.S., Kanafani Z.A. Current concepts in antimicrobial therapy against resistant gram-negative organisms: Extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin. Proc. 2011;86:250–259. doi: 10.4065/mcp.2010.0674. - DOI - PMC - PubMed
    1. Bush K. Past and Present Perspectives on β-Lactamases. Antimicrob. Agents Chemother. 2018;62 doi: 10.1128/AAC.01076-18. - DOI - PMC - PubMed
    1. Touati A., Mairi A. Carbapenemase-Producing Enterobacterales in Algeria: A Systematic Review. Microb. Drug Resist. Larchmt. N. 2019 doi: 10.1089/mdr.2019.0320. - DOI - PubMed

Grants and funding

LinkOut - more resources